Moneycontrol
HomeNewsIndiaToo early to say second wave over, though there are encouraging signs, says PHFI’s K Srinath Reddy

Too early to say second wave over, though there are encouraging signs, says PHFI’s K Srinath Reddy

Reddy, also an adjunct professor of epidemiology at Harvard, says the heart can be affected directly or indirectly during Covid or after but in most cases people recover. He warns against lowering guard and calls for speeding up vaccination to avert another wave.

June 13, 2021 / 11:12 IST
Story continues below Advertisement
Public Health Foundation of India president Prof K Srinath Reddy.

Prof K Srinath Reddy, President, Public Health Foundation of India (PHFI), and adjunct professor of epidemiology at Harvard’s  TH Chan School of Public Health, says only a small number of people who have had Covid have troubling heart problems or suffer long-term damage to the heart.

During the devastating second coronavirus wave, there have been several reports of people suffering heart attacks even after recovering from Covid. Reddy says the heart can be affected directly or indirectly during Covid or after but in most cases people recover.

Story continues below Advertisement

Under the leadership of Reddy, a former head of the Department of Cardiology at New Delhi’s AIIMS, PHFI has set up five Indian Institutes of Public Health to advance multi-disciplinary health education and research to strengthen the country’s healthcare system, which is the need of the hour. In an interview, Reddy talks about heart and lungs problems and the precautions people recovering from Covid must take. Edited excerpts:

What are the possible heart problems that can arise after Covid? What are the symptoms that one should watch out for after recovery? Is screening of the heart needed even there are no visible symptoms?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show